Pharmabiz10m
DGTR postpones oral hearing in anti-dumping probe on resorcinol imports from China and Japan
DGTR postpones oral hearing in anti-dumping probe on resorcinol imports from China and Japan: Shardul Nautiyal, Mumbai Saturday, February 22, 2025, 08:00 Hrs [IST] The Directorate ...
Pharmabiz10m
Pharma Literati launches course on ‘Patenting in Herbal, Ayush and Nutraceutical products’
Customized to the needs of students, researchers, academicians and industry professionals, Pharma Literati has recently launched India’s first course on ‘Patenting in Herbal, Ayush and Nutraceutical ...
Pharmabiz10m
BioAsia 2025 to host Global Healthcare Leaders to drive transformative innovation
BioAsia 2025 to host Global Healthcare Leaders to drive transformative innovation: Our Bureau, Mumbai Saturday, February 22, 2025, 08:00 Hrs [IST] Bio Asia, Asia's premier life sc ...
Pharmabiz10m
TN APTI to hold seminar on ‘Pioneering Pharmacy Profession’ at Dhanalakshmi University today
TN APTI to hold seminar on ‘Pioneering Pharmacy Profession’ at Dhanalakshmi University today: Peethaambaran Kunnathoor, Chennai Saturday, February 22, 2025, 08:00 Hrs [IST] In ...
Pharmabiz22h
Chugai obtains Japanese regulatory approval for Tecentriq for additional indication of alveolar soft part sarcoma, an ultra-rare disease
Chugai obtains Japanese regulatory approval for Tecentriq for additional indication of alveolar soft part sarcoma, an ultra-rare disease: Tokyo Friday, February 21, 2025, 10:00 Hr ...
Pharmabiz16h
Recce Pharma announces positive clinical data from phase II trial of RECCE 327 gel in acute bacterial skin & skin structure infections
Recce Pharma announces positive clinical data from phase II trial of RECCE 327 gel in acute bacterial skin & skin structure infections: Sydney Friday, February 21, 2025, 16:00 Hrs ...
Pharmabiz18h
Aidoc receives US FDA clearance for first foundation model-powered clinical artificial intelligence solution
Aidoc receives US FDA clearance for first foundation model-powered clinical artificial intelligence solution: New York Friday, February 21, 2025, 14:00 Hrs [IST] Aidoc, a global l ...
Pharmabiz23h
China NMPA accepts for review GSK’s Nucala NDA to treat patients with chronic obstructive pulmonary disease
China NMPA accepts for review GSK’s Nucala NDA to treat patients with chronic obstructive pulmonary disease: London, UK Friday, February 21, 2025, 09:00 Hrs [IST] GSK plc announ ...
Pharmabiz19h
Septerna discontinues phase 1 clinical trial of SEP-786; plans to advance next-generation oral small molecule PTH1R agonist
Septerna discontinues phase 1 clinical trial of SEP-786; plans to advance next-generation oral small molecule PTH1R agonist: South San Francisco, California Friday, February 21, 2 ...
Pharmabiz14h
Anixa Biosciences receives approval of protocol amendment for ovarian cancer CAR-T clinical trial
Anixa Biosciences receives approval of protocol amendment for ovarian cancer CAR-T clinical trial: San Jose, California Friday, February 21, 2025, 18:00 Hrs [IST] Anixa Bioscience ...
Pharmabiz14h
The 10th Edition of RaceFor7 to flag off in 21 cities across India simultaneously
The 10th Edition of RaceFor7 to flag off in 21 cities across India simultaneously: Our Bureau, Mumbai Friday, February 21, 2025, 17:30 Hrs [IST] The Organization for Rare Diseases ...
Pharmabiz17h
Ono Pharmaceutical’s vimseltinib to treat tenosynovial giant cell tumour gets US FDA approval
Ono Pharmaceutical’s vimseltinib to treat tenosynovial giant cell tumour gets US FDA approval: Osaka Friday, February 21, 2025, 15:00 Hrs [IST] Ono Pharmaceutical, one of the la ...